Skip to main content

Day: February 19, 2025

Locafy Limited Highlights Growth and Strategic Partnerships in Recent Investor Presentations

Company Showcased Fathom Holdings Partnership with Breakout Investors and Shared Latest Developments on Planet MicroCap Podcast PERTH, Australia, Feb. 19, 2025 (GLOBE NEWSWIRE) — Locafy Limited (Nasdaq: LCFY, LCFYW) (“Locafy” or the “Company”), a globally recognized leader in location based digital marketing solutions, with market leading SEO capabilities, recently participated in two investor-focused presentations, highlighting its latest business developments and strategic initiatives. Breakout Investors Presentation with Fathom Holdings (NASDAQ: FTHM)Locafy CEO Gavin Burnett joined Breakout Investors alongside Fathom Holdings CEO Marco Fregenal to discuss their partnership, which is designed to enhance real estate professionals’ digital presence through advanced SEO solutions. The collaboration leverages Locafy’s proprietary...

Continue reading

Compass Diversified Director James Bottiglieri Announces Retirement

WESTPORT, Conn., Feb. 19, 2025 (GLOBE NEWSWIRE) — Compass Diversified Holdings (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market businesses, announced today that current director James J. Bottiglieri (“Jim”) advised the Board of Directors (the “Board”) on February 14, 2025 that he plans to retire prior to the Company’s 2025 annual shareholders meeting (the “2025 Annual Meeting”). Mr. Bottiglieri will remain on the Company’s Board and as a member of each of the Company’s Nominating and Corporate Governance Committee and Audit Committee up and until the Company’s 2025 Annual Meeting. Mr. Bottiglieri joined the Board in December of 2005. He served as the Company’s Chief Financial Officer and as an Executive Vice President of the Company’s Manager from 2005 to 2013. The Company does not currently intend to fill...

Continue reading

Torr Metals Identifies >3 Kilometer Geophysical Trend Coincident with Historical High-Grade Gold Mineralization at Filion

Figure 1. West FilionA. VLF-EM inversion model displaying conductivity depth slice at 50 meters with annotated interpretations and overlying 2023 humus soil sampling results. B. Vertical derivative of the residual magnetic intensity (RMI) ground magnetic survey.Figure 2. The Filion Gold ProjectThe Filion Gold Project is strategically positioned near Ontario’s provincial infrastructure, where 2023 soil sampling and historical gold data have revealed key targets for follow-up in 2025.VANCOUVER, British Columbia, Feb. 19, 2025 (GLOBE NEWSWIRE) — via IBN – Torr Metals Inc. (“Torr” or the “Company“) (TSX-V: TMET.V) is pleased to announce the identification of nine highly prospective, east-west trending high-resistivity geophysical anomalies, bounded by highly conductive interpreted shear structures, at...

Continue reading

Daxor Corporation Announces New Data on Blood Volume Analysis from Duke and Yale Universities Presented at THT 2025

Two Groundbreaking Studies on Fluid Management: Pulmonary Artery Pressure Monitoring Falls Short, New Diuretic Insights Emerge Oak Ridge, TN, Feb. 19, 2025 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces groundbreaking new studies from Duke University Medical Center and Yale School of Medicine, presented at the Technology and Heart Failure Therapeutics Conference (THT). Held from February 11-13, 2025, at the Omni Boston Hotel at the Seaport, the event gathered leading experts in heart failure innovation. The studies provide critical insights using Daxor’s Blood Volume Analysis (BVA) technology, highlighting the superior accuracy for fluid measurement by BVA compared to the limited accuracy of pulmonary artery pressure monitoring, while also unveiling new findings...

Continue reading

BranchOut Food Welcomes Jesse Thomas as Chief Brand Officer to Drive Direct-to-Consumer and Brand Strategy

E-commerce Expansion and Brand Acceleration to Drive New Revenue Streams and Maximize Market Penetration Key Focus Areas for Jesse Thomas:Build & Launch BranchOut’s DTC Website Expand Product Line onto Amazon & other DTC Platforms Develop & Grow Email Subscription Program Launch Wholesale Portal for Independent Retailers Oversee Digital Advertising & Social Media StrategyBEND, Ore., Feb. 19, 2025 (GLOBE NEWSWIRE) — BranchOut Food Inc. (NASDAQ: BOF), a pioneer in the patented GentleDry™ dehydration technology, today announces the appointment of Jesse Thomas as its Chief Brand Officer. In this role, Thomas will lead the company’s brand and marketing strategy, with a particular focus on expanding BranchOut’s direct-to-consumer (DTC) business, complementing its rapidly growing branded retail, private...

Continue reading

American Rebel Light Beer Continues Rapid Expansion of National Distribution Footprint adding Iowa’s Mahaska Bottling Company

American Rebel Holdings IncAmerican Rebel Light Beer Continues Rapid Expansion of National Distribution Footprint adding Iowa’s Mahaska Bottling CompanyAmerican Rebel Light to be served at Knoxville Raceway the “Sprint Car Capital of the World” and the Dingus Lounge “Iowa’s Most Notorious Bar” Nashville, TN, Feb. 19, 2025 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), creator of American Rebel Beer (americanrebelbeer.com) and a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel (americanrebel.com), proudly announces its strategic expansion into Iowa through a partnership with Mahaska Bottling Company (mahaska.com). This move is a significant milestone in the Company’s broader...

Continue reading

Predictive Oncology Announces Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

PITTSBURGH, Feb. 19, 2025 (GLOBE NEWSWIRE) — Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), a leader in AI-driven drug discovery and biologics, today announced that it has entered into definitive agreements for the purchase and sale of 363,336 shares of common stock at a purchase price of $1.50 per share in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or about February 19, 2025, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The gross proceeds to the Company from the offering are expected to be $545,004 before deducting placement agent fees and other offering expenses payable by the Company. The Company intends to use...

Continue reading

electroCore’s Truvaga™ Now Available on Amazon®

Leading Direct to Consumer Vagus Nerve Stimulator Available for Purchase on World’s Largest Retail Platform ROCKAWAY, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that its flagship wellness product, Truvaga Plus, is now available for purchase on Amazon. Truvaga Plus is a hand-held vagus nerve stimulator designed to elevate the day-to-day experience through quick and gentle activation of your vagus nerve. The product is designed to provide stress relief, improve sleep, enhance peace of mind and improve focus. Dan Goldberger, CEO of electroCore, commented, “Making Truvaga Plus available on Amazon.com allows us to showcase our flagship wellness product to a wider audience through a platform that is used every day by consumers...

Continue reading

EFFECTS OF EB613 TABLETS [ORAL PTH(1-34)] ON TRABECULAR AND CORTICAL BONE USING 3D-DXA: POST-HOC RESULTS FROM PHASE 2 STUDY Accepted for Oral Presentation at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

JERUSALEM , Feb. 19, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptide and protein replacement therapies in tablet form, today announced that the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO) Scientific Programme Committee has accepted both submitted abstracts related to EB613 for presentation at the WCO-IOF-ESCEO congress. The congress will take place at the Roma Convention Center, Rome, Italy from April 10 to April 13, 2025. EB613 is being developed as the first once-daily oral anabolic (bone forming) PTH(1-34) tablet treatment to support earlier osteoanabolic intervention, for high-risk post-menopausal women with osteoporosis. In a Placebo-controlled Phase 2 study, 6 months of EB613 treatment demonstrated...

Continue reading

Asset Entities Inc. Regains Compliance with Nasdaq Listing Rule 5550(b)(1)

DALLAS, Feb. 19, 2025 (GLOBE NEWSWIRE) — Asset Entities Inc. (“Asset Entities” or the “Company”) (NASDAQ: ASST), a provider of digital marketing and content delivery services across Discord, TikTok, and other social media platforms, and a Ternary Payment Platform company, today announced that it has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires minimum stockholders’ equity of $2.5 million. On February 18, 2025, the staff (the “Staff”) of the Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) notified the Company that based on the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 14, 2025, the Staff has determined that the Company complies with Listing Rule 5550(b)(1). The Staff further advised the Company that if the Company fails...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.